Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study
作者： Mustapha Norlaili , Shaharuddin Bakiah , Embong Zunaina
关键词: Medicine 、 Astigmatism 、 Laser coagulation 、 Macular edema 、 Triamcinolone acetonide 、 Visual acuity 、 Ophthalmology 、 Acetonide 、 Diabetic retinopathy 、 Blood–retinal barrier
摘要: Background Diabetic macular oedema is the leading causes of blindness. Laser photocoagulation reduces risk visual loss. However recurrences are common and despite laser treatment, patients with diabetic experienced progressive loss vision. Stabilization blood retinal barrier introduces a rationale for intravitreal triamcinolone treatment in oedema. This study intended to compare best corrected acuity (BCVA) index (MEI) at 3 month primary between acetonide (IVTA) photocoagulation.
biomedcentral.com
springer.com
paperity.org参考文章(18)
A. Özkiris, C. Evereklioglu, K. Erkiliç, N. Tamçelik, E. Mirza, Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. European Journal of Ophthalmology. ,vol. 14, pp. 543- 549 ,(2004) , 10.1177/112067210401400615
Pascale Massin, François Audren, Belkacem Haouchine, Ali Erginay, Jean-François Bergmann, Rym Benosman, Charles Caulin, Alain Gaudric, Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology. ,vol. 111, pp. 218- 224 ,(2004) , 10.1016/J.OPHTHA.2003.05.037
C.P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer, Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales Ophthalmology. ,vol. 110, pp. 1677- 1682 ,(2003) , 10.1016/S0161-6420(03)00475-5
S K Gibran, A Cullinane, S Jungkim, P E Cleary, Intravitreal triamcinolone for diffuse diabetic macular oedema. Eye. ,vol. 20, pp. 720- 724 ,(2006) , 10.1038/SJ.EYE.6701992
F SUTTER, J SIMPSON, M GILLIES, Intravitreal triamcinolone for diabetic macular edema that persists after laser treatmentThree-monthefficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial Ophthalmology. ,vol. 111, pp. 2044- 2049 ,(2004) , 10.1016/J.OPHTHA.2004.05.025
Ates Yanyali, Ahmet F. Nohutcu, Fatih Horozoglu, Erkan Celik, Modified Grid Laser Photocoagulation Versus Pars Plana Vitrectomy With Internal Limiting Membrane Removal in Diabetic Macular Edema American Journal of Ophthalmology. ,vol. 139, pp. 795- 801 ,(2005) , 10.1016/J.AJO.2004.12.017
Hakan Ozdemir, Murat Karacorlu, Serra Arf Karacorlu, Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. American Journal of Ophthalmology. ,vol. 140, pp. 251- 255 ,(2005) , 10.1016/J.AJO.2005.03.004
Figen Batıoğlu, Emin Özmert, Neslihan Parmak, Selcen Çelik, Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema. International Ophthalmology. ,vol. 27, pp. 299- 306 ,(2007) , 10.1007/S10792-007-9072-7
Mohammad H. Dehghan, Hamid Ahmadieh, Alireza Ramezani, Morteza Entezari, Arash Anisian, A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema International Ophthalmology. ,vol. 28, pp. 7- 17 ,(2008) , 10.1007/S10792-007-9097-Y
Charles A Wilson, Bruce A Berkowitz, Yukihiro Sato, Noburo Ando, James T Handa, Eugene de Juan, Treatment With Intravitreal Steroid Reduces Blood-Retinal Barrier Breakdown due to Retinal Photocoagulation Archives of Ophthalmology. ,vol. 110, pp. 1155- 1159 ,(1992) , 10.1001/ARCHOPHT.1992.01080200135041